MSCRF Commercialization Program RFA Grant

The MSCRF Commercialization Program aims to advance human stem cell research for the prevention and treatment of diseases. It supports Maryland-based companies in developing technologies with commercial potential, offering up to $500,000 in funding for collaborative projects. The program encourages partnerships between public and private sectors to enhance research and technology development, emphasizing the importance of stem cell therapies in addressing critical health challenges.

NOTE: Applicant PIs are encouraged to register in the TEDCO online submission system at least one month before the Application Submission Deadline.
Purpose
The purpose of the Fund is to promote state-funded stem cell research and cures through grants and loans to public and private entities in the state.
Stem cell research offers extraordinary promise for new medical therapies and a better understanding of the devastating diseases of our time. The development of new medical strategies for the prevention, diagnosis, treatment and cure of human diseases, injuries and conditions through human stem cell research is a high priority for the State of Maryland.
Funding Objectives
The Maryland Stem Cell Research Fund (MSCRF) Commercialization Program was created to support translational activities necessary to advance technologies with significant commercial potential to a clinical-stage or to market, whether such technologies are a potential stem cell-based -therapeutic, diagnostic, or tool to market-. Specifically, it is the intent of the Commercialization Program to foster the commercialization of such technologies being developed by Maryland-based companies.
It is also the intent of the Program to foster collaborations between the private and public sectors. With the strategic goal to enhance collaboration between research institutions and businesses in Maryland, the program provides an opportunity to access supplementary funding (“Second-tier Funding”) for advancing technology development in cases where there is potential for collaboration between a research institution and a commercial entity. To access the Second-tier Funding, the applicant must establish a collaborative relationship with a Maryland-based research institution through which specific research activities integral to the research project will be conducted in the research institution.
Award Information
Commercialization awards are capped at $400,000 unless the applicant proposes (and demonstrates a commitment to) a collaboration with a research institution in Maryland. Under those terms, an additional $100,000 (‘Second-tier Funding’) may be requested for a total award of $500,000.
Commercialization projects, including all subcontracts, must be completed within 12 months of the date of the award.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.